2025年4月16日 周三
Home > Archive>Volume 24, Issue 8, 2016 >855-859
PDF HTML XML Export Cite reminder
The Research Progress of Matrix Metalloproteinase-9 in Atherosclerosis
CSTR:
[cstr]
Author:
Affiliation:

Guangdong Medical College, Zhanjiang, Guangdong 524023, China)

Clc Number:

R54

  • Article
    • | |
  • Metrics
    • |
  • Reference [37]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Matrix metalloproteinase-9 (MMP-9), a proteinase containing Zn2+ mostly expressed in macrophages, has involved in synthesis and degradation of extracellular matrix, as well as regulation of inflammatory mediators, which facilitated the initiation and exacerbation of atherosclerosis and vascular wall remodeling, leading to the occurrence of cardiovascular events. In this review, we focused on the research progress of MMP-9 in atherosclerosis and introduced the predicting value of MMP-9 for acute myocardial infarction and cardiac remodeling of post-myocardial infarction.

    Reference
    [1] Lina B, Robert F, Gemma V.Update on lipids, inflammation and atherothrombosis.Thromb Haemost, 1,5(Suppl1):S34-S42.
    [2] Ketelhuth DF, Back M.The role of matrix metalloproteinases in atherothrombosis.Curr Atheroscler Rep, 1,3(2):162-169.
    [3] Yonggang M, Andriy Y, Michael E, et al.Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis.Atherosclerosis, 4,2(1):231-233.
    [4] Deleon-Pennell KY, Altara R, Yabluchanskiy A, et al.The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction.IUBMB Life, 5,7(8):611-618.
    [5] Sharon D, Harry VG, Allison AE.Macrophage diversity in renal injury and repair.Clin Invest, 2008(11), 118:3 522-530.
    [6] Newby AC.Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability.Arterioscler Thromb Vasc Biol, 8,8(12):2 108-114.
    [7] Lin J, Kakkar V, Lu X.Impact of matrix metalloproteinases on atherosclerosis.Curr Drug Targets, 4,5(4):442-453.
    [8] 石健, 候静波.基质金属蛋白酶与动脉粥样硬化关系研究新进展.国际心血管病杂志, 3,0(1):25-27.
    [9] 丛晓强, 猛晓萍, 李颖.基质金属蛋白酶在动脉粥样硬化中的作用研究进展.中国动脉硬化杂志, 7,5(5):397-400.
    [10] Ma L, Guan Y, Du Z.Salvianolic acid B down-regulates matrix metalloproteinase-9 activity and expression in tumor necrosis factor-α-induced human coronary artery endothelial cells.Chinese Medical Journal, 5,8(19):2 658-663.
    [11] Grigoryan A, Dimitrova A, Betova T, et al.Expressional changes of matrix metalloproteinases -2 and -9 in abdominal aorta in patients with atherosclerosis .Cardiovasc Res, 4,3(Suppl1):S86-S87.
    [12] Zorina S, Chad J, Denis G, et al.Targeted disruption of the matrix mtalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.Circulation Research, 2,1(9):852-859.
    [13] Yan C, Boyd DD.Regulation of matrix metalloproteinase gene expression.J Cell Physiol, 7,1(1):19-26.
    [14] 张慧娜.Sirt1对血管平滑肌细胞迁移的影响及分子机制研究.中国北京:中国协和医科大学, 2008; 9-69.
    [15] 胡艺琼, 刘先哲.转化生长因子β对动脉粥样硬化中血管平滑肌细胞的作用及其影响.时珍国医国药, 8,9(1):167-169.
    [16] Lemaitre V, Kim HE, Forney-Prescott M, et al.Transgenic expression of matrix metalloproteinase-9 modulates collagen deposition in a mouse model of atherosclerosis.Atherosclerosis, 9,5(1):107-112.
    [17] Toutouzas K, Synetos A, Nikolaou C, et al.Matrix metalloproteinases and vulnerable atheromatous plaque.Curr Top Med Chem, 2,2(10):1 166-180.
    [18] Wagsater D, Zhu C, Bjorkegren J, et al.MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse.Int J Mol Med, 1,8(2):247-253.
    [19] Hamed GM, Fattah MF.Clinical relevance of matrix metalloproteinase-9 in patients with acute coronary syndrome.Clin Appl Thromb-Hemost, 5,1(8):705-711.
    [20] Gomez-Hernandez A, Sanchez-Galan E, Ortego M, et al.Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.Am J Cardiol, 8,2(1):12-18.
    [21] Egerai S, Alessia N, Marika M, et al.Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition.Atherosclerosis, 4,2(1):17-24.
    [22] Van Vré EA, Ait-Oufella H, Tedgui A, et al.Apoptotic cell death and efferocytosis in atherosclerosis.Arterioscler Thromb Vasc Biol, 2,2(4):887-893.
    [23] Martin RB, Gerard IE, Stephen MS, et al.Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques.Clin Invest, 5,5(5):2 266-274.
    [24] Stintzing S, Heuschmann P, Barbera L, et al.Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis.Ann Vasc Surg, 5,9(3):310-319.
    [25] Toutouzas K, Synetos A, Nikolaou C, et al.Matrix metalloproteinases and vulnerable atheromatous plaque.Curr Top Med Chem, 2,2(10):1 166-180.
    [26] Boyle JJ, Bowyer DE, Weissberg PL, et al.Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions.Arterioscler Thromb Vasc Biol, 1,1(9):1 402-407.
    [27] Newby AC.Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.Physiol Rev, 5,5(1):1-31.
    [28] Wu H, Bai X, Chen D, et al.Association of Genetic Polymorphisms in Matrix Metalloproteinase-9 and Coronary Artery Disease.Genet Test Mol Biomarkers, 3,7(9):707-712.
    [29] Silvello D, Narvaes LB, Albuquerque LC, et al.Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis:higher MMP-9 levels are associated with plaque vulnerability.Biomarkers, 4,9(1):49-55.
    [30] Domenico C, Francesco C, Antonino B, et al.Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction.Am J Cardiol, 5,6(4):215-219.
    [31] Tan C, Liu Y, Li W, et al.Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis.Atherosclerosis, 4,2(1):199-203.
    [32] Papakonstantinou E, Karakiulakis G, Batzios S, et al.Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.Respir Res, 5,6(1):1-12.
    [33] Liu N, Huang J, Sun S, et al.Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors .Int J Clin Exp Med, 5,8(4):6 495-501.
    [34] Pasquale A, M,Hammed A, Laura R, et al.Matrix metalloproteinase 9 and transglutanminase 2 expression at the ocular surface in patients with different forms of dry eye disease.Ophthalmology, 5,2(1):62-71.
    [35] Ducharme A, Frantz S, Aikawa M, et al.Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.J Clin Invest, 0,6(1):55-62.
    [36] Zamilpa R, Ibarra J, de Castro Bras LE, et al.Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.J Mol Cell Cardiol, 2,3(5):599-608.
    [37] Halade GV, Jin YF, Lindsey ML.Matrix metalloproteinase (MMP)-9:a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation.Pharmacol Ther, 3,9(1):32-40.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

TONG Hui-Yu, HUANG Yu-Li, HU Yun-Zhao. The Research Progress of Matrix Metalloproteinase-9 in Atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(8):855-859.

Copy
Share
Article Metrics
  • Abstract:1556
  • PDF: 1522
  • HTML: 0
  • Cited by: 0
History
  • Received:November 02,2015
  • Revised:December 30,2015
  • Online: July 25,2016
Article QR Code

You are the 31848 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025